Table 2 Functional roles of RNA methylation and their regulators in esophageal cancer
|
RNA methylation type |
RNA methylation regulator |
Target RNA |
Downstream molecular mechanism |
Phenotype |
Role in esophageal cancer |
Reference |
|
m 6A |
METTL3, YTHDF2 |
APC |
Wnt/β-catenin pathway |
Aerobic glycolysis, tumorigenesis |
Oncogene |
|
|
METTL3, YTHDF3 |
EGR1 |
Snail signaling |
Metastasis |
Oncogene |
||
|
METTL3 |
TNFR1 |
MAPK & NF-κB pathway |
Tumorigenesis, proliferation, migration, invasion |
Oncogene |
||
|
METTL3 |
GAS5 |
miR3912-5p/RALYL |
Tumorigenesis |
Oncogene |
||
|
METTL3 |
pri-miR-20a-5p |
miR-20a-5p/NFIC |
Metastasis, invasion, migration |
Oncogene |
||
|
METTL3 |
NOTCH1 |
Notch signaling pathway |
Invasion, migration, proliferation, tumorigenesis |
Oncogene |
||
|
METTL3 |
GLS2 |
Metastasis |
Oncogene |
|||
|
METTL3 |
AKT signaling pathway |
Proliferation, invasion |
Oncogene |
|||
|
METTL3 |
p21-axis |
Proliferation |
Oncogene |
|||
|
METTL3 |
COL12A1/MAPK signaling pathway |
Tumorigenesis |
Oncogene |
|||
|
METTL3 |
PI3K/AKT signaling pathway |
Proliferation, invasion, migration |
Oncogene |
|||
|
METTL14 |
miR-99a-5p |
TRIB2/HDAC2/AKT/mTOR/S6K1 |
Stemness, radioresistance |
Oncogene |
||
|
WTAP, YTHDF2 |
CPSF4 |
Proliferation, invasion, migration |
Oncogene |
|||
|
WTAP |
ki67 and Snail |
Proliferation, migration |
Oncogene |
|||
|
ALKBH5 |
CASC8 |
hnRNPL/Bcl2/caspase3 pathway |
Proliferation, chemoresistance |
Oncogene |
||
|
ALKBH5 |
pri-miR-194-2 |
RAI1/Hippo signaling pathway |
Tumorigenesis, metastasis, migration |
Tumor suppressor gene |
||
|
ALKBH5 |
LINC00278 |
AR signaling pathway |
Proliferation |
Oncogene |
||
|
ALKBH5 |
miR-193a-3p |
Proliferation, migration, invasion |
Tumor suppressor gene |
|||
|
ALKBH5 |
Proliferation, invasion |
Tumor suppressor gene |
||||
|
ALKBH5 |
Migration, invasion, tumorigenesis |
Tumor suppressor gene |
||||
|
FTO, YTHDF2 |
LINC00022 |
p21 |
Tumorigenesis |
Oncogene |
||
|
FTO, YTHDF1 |
HSD17B11 |
Lipid metabolism |
Tumorigenesis, migration, invasion |
Oncogene |
||
|
FTO, YTHDF1 |
ERBB2 |
Metastasis, tumorigenesis |
Oncogene |
|||
|
FTO |
MMP13 |
Proliferation, migration |
Oncogene |
|||
|
YTHDF1 |
HK2 |
Aerobic glycolysis |
Oncogene |
|||
|
IGF2BP2 |
TK1 |
Migration, invasion |
Oncogene |
|||
|
HNRNPA2B1 |
ACLY/ACC1 |
Proliferation, invasion, migration |
Oncogene |
|||
|
YTHDC2 |
Several cancer-related signaling pathways |
Proliferation |
Tumor suppressor gene |
|||
|
m 5C |
NSUN2 |
NMR |
BPTF/MMP3/MMP10 |
Chemoresistance, migration, invasion, proliferation |
Oncogene |
|
|
NSUN2 |
GRB2 |
PI3K/AKT and ERK/MAPK |
Tumorigenesis, invasion, migration |
Oncogene |
||
|
NSUN2 |
Cancer-related genes |
Proliferation, radiochemotherapy resistance |
Oncogene |
|||
|
YBX1 |
c-Myc |
Proliferation, metastasis |
Oncogene |
|||
|
TET3 |
HOXB2/c-MYC/NANOG pathway |
Stemness |
Oncogene |
|||
|
TET2 |
Proliferation, migration |
Tumor suppressor gene |
||||
|
TET1 |
Migration, invasion |
Tumor suppressor gene |
||||
|
TET1 |
Proliferation |
Tumor suppressor gene |
||||
|
m 7G |
METTL1/WDR4 |
tRNA |
RPTOR-pULK1 |
Proliferation, tumorigenesis |
Oncogene |